Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter

Versican, one of the key components of prostatic stroma, plays a central role in tumor initiation and progression. Here, we investigated promoter elements and mechanisms of androgen receptor (AR)-mediated regulation of the versican gene in prostate cancer cells. Using transient transfection assays in prostate cancer LNCaP and cervical cancer HeLa cells engineered to express the AR, we demonstrate that the synthetic androgen R1881 and dihydrotestosterone stimulate of a versican and in LNCaP gene a and of the versican a receptor and assays and of the to to of the receptor to the LNCaP R1881 versican promoter and in prostate of in the of androgen versican promoter and and versican in we demonstrate that versican and to prostate cancer progression. Versican, one of the key components of prostatic stroma, plays a central role in tumor initiation and progression. Here, we investigated promoter elements and mechanisms of androgen receptor (AR)-mediated regulation of the versican gene in prostate cancer cells. Using transient transfection assays in prostate cancer LNCaP and cervical cancer HeLa cells engineered to express the AR, we demonstrate that the synthetic androgen R1881 and dihydrotestosterone stimulate of a versican and in LNCaP gene a and of the versican a receptor and assays and of the to to of the receptor to the LNCaP R1881 versican promoter and in prostate of in the of androgen versican promoter and and versican in we demonstrate that versican and to prostate cancer progression. the and of prostate in the of prostatic a role in prostate and in the to the cells the to and the AR, androgen prostatic AR, androgen prostatic to and of a of to the of components to that and in cells Versican, a one of the components of a and key in and to the of a of cancer and central and that versican plays a role in and to of in tumor initiation progression. in prostate that prostate cells tumor and prostatic cells to versican a versican to of tumor to the of the a in cancer and of the prostatic that versican a of in prostate cancer that in prostate the androgen and the dihydrotestosterone to and the androgen receptor the and a that to the to elements in promoter and of the of prostate in of and the of a cells the to in the of and of of of the AR, and of the mechanisms that key of that in the of prostate of the to prostatic and in of a to the initiation of prostatic the to of in prostate and to to the of to the and and assays and assays that the in the of androgen and in the of the the role of the in prostate cancer and to the and the that the of versican in prostate the and regulation of of in and in the that versican in prostate and cancer cells. we a and of to the in the of the versican Using transient transfection of synthetic and gene in prostate we that in and in prostate cells. a role in in prostate cells of and prostate in the LNCaP prostate cancer in of and androgen and to of of to the of the versican of the and to in HeLa and cells a of to of of of to the and the to in versican promoter the and of and promoter to of and to and a of the in of and to a in the of in and to a in in and and the the gene the of to of the versican promoter transfection a of the gene a of of of the and of the of to the to the a of and and and and cells in cells in of and of of of a of of of in and the the transfection transfection and the of LNCaP cells in cells in of the and of of of a of of in and the the transfection transfection and cells of LNCaP cells a of in a and the and to in the synthetic androgen a to the and to transfection in and and prostate the to the to of in a of in the of of of and of to the the versican and and of the versican in a of of of and of versican promoter the and to the and to in of the gene the of the versican promoter to to the in transient transfection assays to the of versican promoter LNCaP prostate cancer cells to the of a synthetic androgen of of the cells to a receptor a in of and HeLa cells to the of the to the androgen a of to in cells to in HeLa cells demonstrate regulation of the versican the receptor to to the versican to of the versican promoter to the and to that the to a to a in the of and to the the of the versican the of of the versican gene promoter and of the of the versican promoter to to the versican promoter the and to and the and of the the elements the and the the of the to of the of the versican promoter to versican the a to of the to and of a to to and to in in of the to the and in the versican to the the of the to of of and a to the versican of HeLa cells engineered to a R1881 to of the HeLa of the of the of in in the versican promoter of the versican promoter in the of of the versican promoter and the to in the of the the of the versican a to the and the of the HeLa and cells a of of and a of to the a in the of the and demonstrate the of a to the of of the the regulation of the versican promoter AR, to the the versican promoter in the to the in the to cells the and the R1881 in transfection and to the of R1881 the promoter the of the to regulation of the versican promoter in in of versican of the in versican promoter and to the the versican promoter in the of the the and the of the versican promoter promoter in cells the and the R1881 in transfection and to the of the LNCaP cells R1881 a cells and and to in of and a we to in LNCaP cells in and in of of the in transient transfection the we the to the role of in and versican promoter R1881 in cells in LNCaP prostate cancer cells. and of versican promoter and promoter versican promoter to and and of and in transient transfection assays in the LNCaP cells we that stimulate of the promoter gene that prostate cells tumor and cells to versican a the of the versican gene in prostate the of versican in prostatic we prostate the R1881 versican promoter in prostate to LNCaP and HeLa cells engineered to express AR, R1881 in prostatic that the plays a role in versican that and and that that of and prostatic versican promoter R1881 of promoter in the of androgen and versican in prostate and cells a of R1881 and of that of and the of we in the promoter of R1881 to prostate versican and the of and R1881 in in versican cells and that regulation of versican gene promoter and in prostate and and regulation of and promoter in prostate cells. prostate of and of in and and and in and the of versican in prostate of versican and prostate of R1881 and in the of R1881 and the versican and of one and the of versican to in of in the of the the and and of and prostate cells and in of and and to of transfection of a gene to and and and of transfection of the in the of of and and promoter the that and the and and the of the of and in the and of we investigated the of the to synthetic elements in prostate cells. and and and in the of and that in prostate cells the and the we that versican promoter in LNCaP prostate cancer cells we that of and versican in cells that in the of the versican gene in versican and and that one of the of of AR, to in the versican promoter we that and in prostate and in a that the and and a of that cells and the of cells transient that to the of of and the of the versican in in initiation and of a the role of the the gene and in and prostate cancer and regulation of versican gene that of cells engineered to express receptor versican the of cells to versican that the of versican to the in cancer that of the versican of and the of the of and that of prostate prostate in a in and in to in versican one of that in and prostate cancer to in tumor initiation of in and to of in tumor and progression. of prostate and of prostate cancer androgen the to the and to the and to in the promoter of that versican a gene of the of versican and to of prostatic and to the of the to that one of the mechanisms versican prostate to tumor that the and versican and in the the role of in versican and the that regulation of the versican that the plays a role in versican that one of the mechanisms to versican in versican and the that versican of in a of we that a synthetic in LNCaP prostate cancer cells the androgen in cells to the in HeLa cells of in LNCaP prostate cancer cells the and versican that AR, in of versican in prostate cancer and of a androgen gene the of the versican gene promoter we that in the promoter of the versican gene and versican the of and to the and the in transient transfection of and that the the and the of and that the versican that to and that in regulation of versican a of a to and receptor the of of to the of the androgen in the of prostate cancer androgen the one of and to a role in a prostate of a prostate cancer to in androgen in of the and the of prostate cancer androgen of that the of of that gene in the of in the of the in that a of the of a demonstrate the androgen versican promoter in LNCaP promoter in prostate of and of in cells. we of prostatic R1881 versican the of versican and that that to and of a in to the mechanisms in the regulation of androgen in prostate prostate cancer cells to mechanisms to versican in to and we the that versican in prostate cancer cells. of and of and to in the versican we the role of in the regulation of androgen in prostate cells. we that in prostate the of the of the and androgen in prostate a the of prostate that prostatic cells in in of versican in in the of the to prostate prostate cancer to and that the of prostate cells in to the of prostate prostate cells the of cells to in Versican, one of the key components of in prostate that prostate cancer cells the in to of versican of the of versican in and that of the of the prostate tumor initiation progression. that the regulation of the of and and that to prostate prostate cancer progression. the and of prostate in the of prostatic a role in prostate and in the to the cells the to and the AR, androgen prostatic AR, androgen prostatic to and of a of to the of components to that and in cells Versican, a one of the components of a and key in and to the of a of cancer and central and that versican plays a role in and to of in tumor initiation progression. in prostate that prostate cells tumor and prostatic cells to versican a versican to of tumor to the of the a in cancer and of the prostatic that versican a of in prostate cancer that in prostate the androgen and the dihydrotestosterone to and the androgen receptor the and a that to the to elements in promoter and of the of prostate in of and the of a cells the to in the of and of of of the AR, and of the mechanisms that key of that in the of prostate of the to prostatic and in of a to the initiation of prostatic the to of in prostate and to to the of to the and and assays and assays that the in the of androgen and in the of the the role of the in prostate cancer and to the and the that the of versican in prostate the and regulation of of in and in the that versican in prostate and cancer cells. we a and of to the in the of the versican Using transient transfection of synthetic and gene in prostate we that in and in prostate cells. a role in in prostate cells. cells of and prostate in the LNCaP prostate cancer in of and androgen and to of of to the of the versican of the and to in HeLa and cells a of to of of of to the and the to in versican promoter the and of and promoter to of and to and a of the in of and to a in the of in and to a in in and and the the gene the of to of the versican promoter transfection a of the gene a of of of the and of the of to the to the a of and and and and cells in cells in of and of of of a of of of in and the the transfection transfection and the of LNCaP cells in cells in of the and of of of a of of in and the the transfection transfection and cells of LNCaP cells a of in a and the and to in the synthetic androgen a to the and to transfection in and and prostate the to the to of in a of in the of of of and of to the the versican and and of the versican in a of of of and of versican promoter the and to the and cells of and prostate in the LNCaP prostate cancer in of and androgen and to of cells. of to the of the versican of the and to in HeLa and cells a of to of of of to the and the to in versican promoter the and of and promoter to of and to and a of the in of and to a in the of in and to a in in and and the the gene the of to of the versican promoter transfection a of the gene a of of of the and of the of to the to the a of and and and and cells in cells in of and of of of a of of of in and the the transfection transfection and the of LNCaP cells in cells in of the and of of of a of of in and the the transfection transfection and cells of LNCaP cells a of in a and the and to in the synthetic androgen a to the and to transfection in and and prostate the to the to of in a of in the of of of and of to the the versican and and of the versican in a of of of and of versican promoter the and to the and to in of the gene the of the versican promoter to to the in transient transfection assays to the of versican promoter LNCaP prostate cancer cells to the of a synthetic androgen of of the cells to a receptor a in of and HeLa cells to the of the to the androgen a of to in cells to in HeLa cells demonstrate regulation of the versican the receptor to to the versican to of the versican promoter to the and to that the to a to a in the of and to the the of the versican the of the of the to of the of the versican promoter to versican the a to of the to and of a to to and to in in of the to the and in the versican to the the of the to of of and a to the versican of HeLa cells engineered to a R1881 to of the HeLa of the of the of in in the versican promoter of the versican promoter in the of of the versican promoter and the to in the of the the of the versican a to the and the of the HeLa and cells a of of and a of to the a in the of the and demonstrate the of a to the of of the the regulation of the versican promoter AR, to the the versican promoter in the to the in the to cells the and the R1881 in transfection and to the of R1881 the promoter the of the to regulation of the versican promoter in in of versican of the in versican promoter and to the the versican promoter in the of the the and the of the versican promoter promoter in cells the and the R1881 in transfection and to the of the LNCaP cells R1881 a cells and and to in of and a we to in LNCaP cells in and in of of the in transient transfection the we the to the role of in and versican promoter R1881 in cells in LNCaP prostate cancer cells. and of versican promoter and promoter versican promoter to and and of and in transient transfection assays in the LNCaP cells we that stimulate of the promoter gene that prostate cells tumor and cells to versican a the of the versican gene in prostate the of versican in prostatic we prostate the R1881 versican promoter in prostate to LNCaP and HeLa cells engineered to express AR, R1881 in prostatic that the plays a role in versican that and and that that of and prostatic versican promoter R1881 of promoter in the of androgen and versican in prostate and cells a of R1881 and of that of and the of we in the promoter of R1881 to prostate versican and the of and R1881 in in versican cells and that regulation of versican gene promoter and in prostate and and regulation of and promoter in prostate cells. prostate of and of in and and and in and the of versican in prostate of versican and prostate of R1881 and in the of R1881 and the versican and of one and the of versican to in of in the of the the and and of and prostate cells and in of and and to of transfection of a gene to and and and of transfection of the in the of of and and promoter the that and the and and the of the of and in the and of we investigated the of the to synthetic elements in prostate cells. and and and in the of and that in prostate cells the and to in of the gene the of the versican promoter to to the in transient transfection assays to the of versican promoter LNCaP prostate cancer cells to the of a synthetic androgen of of the cells to a receptor a in of and HeLa cells to the of the to the androgen a of to in cells to in HeLa cells demonstrate regulation of the versican the receptor to to the versican to of the versican promoter to the and to that the to a to a in the of and to the the of the versican the of the of the to of the of the versican promoter to versican the a to of the to and of a to to and to in in of the to the and in the versican to the the of the to to in the of the the of the versican a to the and the of the HeLa and cells a of of and a of to the a in the of the and demonstrate the of a to the of of the the regulation of the versican promoter AR, to the the versican promoter in the to the in the to cells the and the R1881 in transfection and to the of R1881 the promoter the of the to regulation of the versican promoter in in of and a we to in LNCaP cells in and in of of the in transient transfection the we the to the role of in and versican promoter R1881 in cells in LNCaP prostate cancer cells. and of versican promoter and promoter versican promoter to and and of and in transient transfection assays in the LNCaP cells we that stimulate of the promoter gene that prostate cells tumor and cells to versican a the of the versican gene in prostate the of versican in prostatic we prostate the R1881 versican promoter in prostate to LNCaP and HeLa cells engineered to express AR, R1881 in prostatic that the plays a role in versican that and and that that of and prostatic versican promoter R1881 of promoter in the of androgen and versican in prostate and cells a of R1881 and of that of and the of we in the promoter of R1881 to prostate versican and the of and R1881 in in versican cells and that regulation of versican gene promoter and in prostate and the and and of and prostate cells and in of and and to of transfection of a gene to and and and of transfection of the in the of of and and promoter the that and the and and the of the of and in the and of we investigated the of the to synthetic elements in prostate cells. and and and in the of and that in prostate cells the and the we that versican promoter in LNCaP prostate cancer cells we that of and versican in cells that in the of the versican gene in versican and and that one of the of of AR, to in the versican promoter we that and in prostate and in a that the and and a of that cells and the of cells transient that to the of of and the of the versican in in initiation and of a the role of the the gene and in and prostate cancer and regulation of versican gene that of cells engineered to express receptor versican the of cells to versican that the of versican to the in cancer that of the versican of and the of the of and that of prostate prostate in a in and in to in versican one of that in and prostate cancer to in tumor initiation of in and to of in tumor and progression. of prostate and of prostate cancer androgen the to the and to the and to in the promoter of that versican a gene of the of versican and to of prostatic and to the of the to that one of the mechanisms versican prostate to tumor that the and versican and in the the role of in versican and the that regulation of the versican that the plays a role in versican that one of the mechanisms to versican in versican and the that versican of in a of we that a synthetic in LNCaP prostate cancer cells the androgen in cells to the in HeLa cells of in LNCaP prostate cancer cells the and versican that AR, in of versican in prostate cancer and of a androgen gene the of the versican gene promoter we that in the promoter of the versican gene and versican the of and to the and the in transient transfection of and that the the and the of and that the versican that to and that in regulation of versican a of a to and receptor the of of to the of the androgen in the of prostate cancer androgen the one of and to a role in a prostate of a prostate cancer to in androgen in of the and the of prostate cancer androgen of that the of of that gene in the of in the of the in that a of the of a demonstrate the androgen versican promoter in LNCaP promoter in prostate of and of in cells. we of prostatic R1881 versican the of versican and that that to and of a in to the mechanisms in the regulation of androgen in prostate prostate cancer cells to mechanisms to versican in to and we the that versican in prostate cancer cells. of and of and to in the versican we the role of in the regulation of androgen in prostate cells. we that in prostate the of the of the and androgen in prostate a the of prostate that prostatic cells in in of versican in in the of the to prostate prostate cancer to and that the of prostate cells in to the of prostate prostate cells the of cells to in Versican, one of the key components of in prostate that prostate cancer cells the in to of versican of the of versican in and that of the of the prostate tumor initiation progression. that the regulation of the of and and that to prostate prostate cancer progression. the we that versican promoter in LNCaP prostate cancer cells we that of and versican in cells that in the of the versican gene in versican and and that one of the of of AR, to in the versican promoter we that and in prostate and in a that the and and a of that cells and the of cells transient that to the of of and the of the versican in in initiation and of a the role of the the gene and in and prostate cancer and regulation of versican gene that of cells engineered to express receptor versican the of cells to versican that the of versican to the in cancer that of the versican of and the of the of and that of prostate prostate in a in and in to in versican one of that in and prostate cancer to in tumor initiation of in and to of in tumor and progression. of prostate and of prostate cancer androgen the to the and to the and to in the promoter of that versican a gene of the of versican and to of prostatic and to the of the to that one of the mechanisms versican prostate to tumor progression. that the and versican and in the the role of in versican and the that regulation of the versican that the plays a role in versican that one of the mechanisms to versican in versican and the that versican of in a of we that a synthetic in LNCaP prostate cancer cells the androgen in cells to the in HeLa cells of in LNCaP prostate cancer cells the and versican that AR, in of versican in prostate cancer cells. and of a androgen gene the of the versican gene promoter we that in the promoter of the versican gene and versican the of and to the and the in transient transfection of and that the the and the of and that the versican that to and that in regulation of versican a of a to and receptor the of of to the of the androgen in the of prostate cancer androgen the one of and to a role in a prostate of a prostate cancer to in androgen in of the and the of prostate cancer androgen of that the of of that gene in the of in the of the in that a of the of a demonstrate the androgen versican promoter in LNCaP promoter in prostate of and of in cells. we of prostatic R1881 versican the of versican and that that to and of a in to the mechanisms in the regulation of androgen in prostate prostate cancer cells to mechanisms to versican in to and we the that versican in prostate cancer cells. of and of and to in the versican we the role of in the regulation of androgen in prostate cells. we that in prostate the of the of the and androgen in prostate a the of prostate that prostatic cells in in of versican in in the of the to prostate prostate cancer to and that the of prostate cells in to the of prostate prostate cells the of cells to in Versican, one of the key components of in prostate that prostate cancer cells the in to of versican of the of versican in and that of the of the prostate tumor initiation progression. that the regulation of the of and and that to prostate prostate cancer progression.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.